Centessa Pharmaceuticals

IPO

Centessa Pharmaceuticals is a next-gen biopharmaceutical company reshaping traditional drug development with its asset-centric R&D model.

Centessa Pharmaceuticals is a healthcare company in United States, founded in 2021. It has raised $550.0M across 2 rounds, most recently a $300.0M Corporate Round in April 2024.

Employees
51–200
Founded
2021
Business Model
B2B
Total Funding
$550.0M
Last Round
$300.0M Corporate RoundApr 2024
Rounds
2
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 2 investors for this company. to use credits for reveals, or explore the API.

About

Centessa Pharmaceuticals is a clinical-stage biopharmaceutical company built on an asset-centric R&D model, formed through the merger of multiple biotech companies to pursue first-in-class and best-in-class medicines. Its pipeline spans discovery-stage to late-stage programs in neuroscience, including an orexin receptor 2 (OX2R) agonist program for sleep-wake disorders and its proprietary LockBody antibody technology platform. In 2026 Centessa agreed to be acquired by Eli Lilly and Company for up to $7.8 billion.

Funding & Exit History

Data from Indexed.vcUpdated
Corporate RoundCorporate RoundApr 2024
$300.0M

2 more events

  • IPO2021
  • Series A20212 investors

Funding: Series A through Corporate Round. Amounts, valuations, and investors where available.

Investors

Tech & App Stack

8 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

  • Marketing & SEO ×3
  • Backend ×2
  • Cloud/Infrastructure ×1
  • DevOps ×1
  • Other ×1

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Companies in related industries

Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Healthcare
Series ATotal funding$3.0BJan 2022
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Healthcare
Growth EquityTotal funding$2.7BJul 2026
AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Healthcare
Private EquityTotal funding$2.3BFeb 2020
Calico

Calico researches human aging using advanced technologies and model systems, applying that knowle...

South San Francisco, United States201–500Healthcare
Corporate RoundTotal funding$2.3BJun 2018
PHC

PHC is a leading provider of diabetes monitoring systems, specialized laboratory equipment, and c...

Minato, Japan5001–10000Healthcare
Private EquityTotal funding$1.9BMar 2021
Oscar HealthIPO

Oscar Health uses technology to deliver simple, personalized health insurance and member-care exp...

New York, United States1001–5000Healthcare
ConvertibleTotal funding$1.8BOct 2025

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Centessa Pharmaceuticals on Indexed.vc
<a href="https://indexed.vc/companies/centessa-pharmaceuticals"><img src="https://indexed.vc/api/badge/company/centessa-pharmaceuticals" alt="Centessa Pharmaceuticals on Indexed.vc" width="260" height="76" /></a>